- Home
- CRBU vs XBIT Comparison
CRBU vs XBIT Comparison
Compare CRBU & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- XBIT
- Stock Information
- Founded
- CRBU 2011
- XBIT 2005
- Country
- CRBU United States
- XBIT United States
- Employees
- CRBU N/A
- XBIT N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- XBIT Pharmaceuticals and Biotechnology
- Sector
- CRBU Health Care
- XBIT Health Care
- Exchange
- CRBU Nasdaq
- XBIT Nasdaq
- Market Cap
- CRBU 236.3M
- XBIT 217.5M
- IPO Year
- CRBU 2021
- XBIT 2015
- Fundamental
- Price
- CRBU $2.68
- XBIT $7.55
- Analyst Decision
- CRBU Strong Buy
- XBIT
- Analyst Count
- CRBU 4
- XBIT 0
- Target Price
- CRBU $14.00
- XBIT N/A
- AVG Volume (30 Days)
- CRBU 1.5M
- XBIT 47.8K
- Earning Date
- CRBU 11-06-2024
- XBIT 11-15-2024
- Dividend Yield
- CRBU N/A
- XBIT N/A
- EPS Growth
- CRBU N/A
- XBIT N/A
- EPS
- CRBU N/A
- XBIT N/A
- Revenue
- CRBU $11,475,000.00
- XBIT N/A
- Revenue This Year
- CRBU N/A
- XBIT N/A
- Revenue Next Year
- CRBU $3.24
- XBIT N/A
- P/E Ratio
- CRBU N/A
- XBIT N/A
- Revenue Growth
- CRBU N/A
- XBIT N/A
- 52 Week Low
- CRBU $1.50
- XBIT $3.51
- 52 Week High
- CRBU $8.33
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- CRBU 72.23
- XBIT 52.29
- Support Level
- CRBU $2.37
- XBIT $7.14
- Resistance Level
- CRBU $3.00
- XBIT $8.32
- Average True Range (ATR)
- CRBU 0.23
- XBIT 0.52
- MACD
- CRBU 0.09
- XBIT 0.01
- Stochastic Oscillator
- CRBU 73.98
- XBIT 48.32
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.